Zobrazeno 1 - 10
of 169
pro vyhledávání: '"María-José Terol"'
Autor:
Francisco‐Javier Peñalver, José‐Antonio Márquez, Soledad Durán, Pilar Giraldo, Alejandro Martín, Carlos Montalbán, Juan‐Manuel Sancho, María‐José Ramírez, María‐José Terol, Francisco‐Javier Capote, Antonio Gutiérrez, Blanca Sánchez, Andrés López, Antonio Salar, Gil Rodríguez‐Caravaca, Miguel Canales, María‐Dolores Caballero, on behalf of GELTAMO (The Spanish Lymphoma Cooperative Group)
Publikováno v:
Cancer Medicine, Vol 8, Iss 16, Pp 6955-6966 (2019)
Abstract Background Consensus is lacking regarding the optimal salvage therapy for patients with follicular lymphoma who relapse after or are refractory to immunochemotherapy. Methods This phase II trial evaluated the efficacy and safety of response
Externí odkaz:
https://doaj.org/article/c0d48b7ace1a4481a9fc9f78ab30071c
Autor:
Blanca Ferrer-Lores, Alfonso Ortiz-Algarra, Alfonso Picó-Peris, Alejandra Estepa-Fernández, Fuensanta Bellvís-Bataller, Glen J. Weiss, Almudena Fuster-Matanzo, Juan Pedro Fernández, Ana Jimenez-Pastor, Rafael Hernani, Ana Saus-Carreres, Ana Benzaquen, Laura Ventura, José Luis Piñana, Ana Belén Teruel, Alicia Serrano-Alcalá, Rosa Dosdá, Pablo Sopena-Novales, Aitana Balaguer-Rosello, Manuel Guerreiro, Jaime Sanz, Luis Martí-Bonmatí, María José Terol, Ángel Alberich-Bayarri
Publikováno v:
EJNMMI Research, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract Background This multicentre retrospective observational study aims to develop imaging-based prognostic and predictive models for relapsed/refractory (R/R) B-cell lymphoma patients undergoing CAR-T therapy by integrating clinical data and ima
Externí odkaz:
https://doaj.org/article/0057ba293b9c45989ef0c7a2fb4073b2
Autor:
Reyes Arranz, Ana García-Noblejas, Carlos Grande, Jimena Cannata-Ortiz, José J. Sánchez, José-Antonio García-Marco, Concepción Aláez, Javier Pérez-Calvo, Pilar Martínez-Sánchez, Blanca Sánchez-González, Miguel-Angel Canales, Eulogio Conde, Alejandro Martín, Eva Arranz, María-José Terol, Antonio Salar, Dolores Caballero
Publikováno v:
Haematologica, Vol 98, Iss 10 (2013)
The prognosis for fit patients with mantle cell lymphoma has improved with intensive strategies. Currently, the role of maintenance/consolidation approaches is being tested as relapses continue to appear. In this trial we evaluated the feasibility, s
Externí odkaz:
https://doaj.org/article/ed4a27045ae94690b3543b11f8af8e50
Autor:
María-Victoria Mateos, José M. Hernández, Miguel T. Hernández, Norma C. Gutiérrez, Luis Palomera, Marta Fuertes, Pedro Garcia-Sanchez, Juán J. Lahuerta, Javier de la Rubia, María-José Terol, Ana Sureda, Joan Bargay, Paz Ribas, Adrian Alegre, Felipe de Arriba, Albert Oriol, Dolores Carrera, José García-Laraña, Ramón García-Sanz, Joan Bladé, Felipe Prósper, Gemma Mateo, Dixie-Lee Esseltine, Helgi van de Velde, Jesús F. San Miguel
Publikováno v:
Haematologica, Vol 93, Iss 4 (2008)
Background New treatment options offering enhanced activity in elderly, newly diagnosed patients with multiple myeloma are required. One strategy is to combine melphalan and prednisone with novel agents. We previously reported an 89% response rate, i
Externí odkaz:
https://doaj.org/article/9f8458fe4c86485e9ba88a9909349e2b
Autor:
Ignacio Torres, Dixie Huntley, Mar Tormo, Marisa Calabuig, Juan Carlos Hernández-Boluda, María José Terol, Carlos Carretero, Paula de Michelena, Ariadna Pérez, José Luis Piñana, Javier Colomina, Carlos Solano, David Navarro
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background To investigate the multi-drug resistant bacteria (MDRB) colonization rate in hematological patients hospitalized for any cause using a multi-body-site surveillance approach, and determine the extent to which this screening strateg
Externí odkaz:
https://doaj.org/article/a0a0c778dcda44e09197459df815c055
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-16 (2021)
Abstract Chronic Lymphocytic Leukemia (CLL) is a hematological malignancy characterized by uncontrolled proliferation of B-cells and severe immune dysfunction. Chemo(immuno)therapies (CIT) have traditionally aimed to reduce tumor burden without fully
Externí odkaz:
https://doaj.org/article/837dd395b20f46089d179242b7385cf4
Autor:
Mariana Bastos-Oreiro, Antonio Gutierrez, Juan Luís Reguera, Gloria Iacoboni, Lucía López-Corral, María José Terol, Valentín Ortíz-Maldonado, Jaime Sanz, Luisa Guerra-Dominguez, Rebeca Bailen, Alberto Mussetti, Pau Abrisqueta, Rafael Hernani, Hugo Luzardo, Juan-Manuel Sancho, Javier Delgado-Serrano, Antonio Salar, Carlos Grande, Leyre Bento, Sonia González de Villambrosía, Daniel García-Belmonte, Anna Sureda, Antonio Pérez-Martínez, Pere Barba, Mi Kwon, Alejandro Martín García-Sancho
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Real-world evidence comparing the efficacy of chimeric antigen receptor (CAR) T-cell therapy against that of the previous standard of care (SOC) for refractory large B-cell lymphoma (LBCL) is scarce. We retrospectively collected data from patients wi
Externí odkaz:
https://doaj.org/article/f4aa2bd4e937434ab71da25c9ec7ae18
Autor:
Isabel Jiménez, Bárbara Tazón-Vega, Pau Abrisqueta, Juan C. Nieto, Sabela Bobillo, Carles Palacio-García, Júlia Carabia, Rafael Valdés-Mas, Magdalena Munuera, Lluís Puigdefàbregas, Genís Parra, Anna Esteve-Codina, Clara Franco-Jarava, Gloria Iacoboni, María José Terol, José Antonio García-Marco, Marta Crespo, Francesc Bosch
Publikováno v:
Biomarker Research, Vol 9, Iss 1, Pp 1-14 (2021)
Abstract Background Mechanisms driving the progression of chronic lymphocytic leukemia (CLL) from its early stages are not fully understood. The acquisition of molecular changes at the time of progression has been observed in a small fraction of pati
Externí odkaz:
https://doaj.org/article/b8be7bd26b3d4fcf833809c39c3cd6a1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Isabel Ródenas‐Quiñonero, Tzu Chen‐Liang, Taida Martín‐Santos, Antonio Salar, Marta Fernández‐González, Carolina Celades, José‐Tomás Navarro, Ana Belén Martínez‐Garcia, Rafael Andreu, Aitana Balaguer, Alejandro Martin García‐Sancho, Mónica Baile, Javier López‐Jiménez, Juan Marquet‐Palomanes, Ana Isabel Teruel, María José Terol, Carmen Benet, Laura Frutos, José Luis Navarro, Jon Uña, Marina Suarez, Montserrat Cortes, José Contreras, Cristina Ruiz, Pilar Tamayo, Jorge Mucientes, Pablo Sopena‐Novales, Laura Reguilón‐Gallego, José Javier Sánchez‐Blanco, Elena Pérez‐Ceballos, Andrés Jerez, Francisco José Ortuño
Publikováno v:
Cancer Medicine. 12:6536-6546
In the workup of follicular lymphoma (FL), bone marrow biopsy (BMB) assessment is a key component of FLIPI and FLIPI2, the most widely used outcome scores. During the previous decade, several studies explored the role of FDG-PET/CT for detecting noda
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ca348bad6dad1b2a84e39e48d04dc42
https://doi.org/10.1002/cam4.5424
https://doi.org/10.1002/cam4.5424